LOGIN  |  REGISTER
Assertio

Recent Insider Transactions - Monopar Therapeutics (NASDAQ: MNPR)

Follow NASDAQ:MNPR Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ MNPR Monopar Therapeutics
Robinson Chandler / director, officer: Chief Executive Officer
03/04/2025
Buy
$31.70
85,759
$2.719M
85,759
NASDAQ MNPR Monopar Therapeutics
Robinson Chandler / director, officer: Chief Executive Officer
03/04/2025
Sell
$31.70
1,759
$56K
63,091
NASDAQ MNPR Monopar Therapeutics
Cittadine Andrew / officer: Chief Operating Officer
03/04/2025
Buy
$31.70
43,445
$1.377M
43,445
NASDAQ MNPR Monopar Therapeutics
STARR CHRISTOPHER M / director
03/04/2025
Buy
$31.70
11,365
$360K
11,365
NASDAQ MNPR Monopar Therapeutics
KLAUSNER ARTHUR J / director
03/04/2025
Buy
$31.70
11,365
$360K
11,365
NASDAQ MNPR Monopar Therapeutics
Anderson Raymond / director
03/04/2025
Buy
$31.70
11,365
$360K
11,365
NASDAQ MNPR Monopar Therapeutics
Talukdar Lavina / director
03/04/2025
Buy
$31.70
5,683
$180K
5,683
NASDAQ MNPR Monopar Therapeutics
Tsuchimoto Kim R / director
03/04/2025
Buy
$31.70
11,365
$360K
11,365
NASDAQ MNPR Monopar Therapeutics
Vu Quan Anh / officer: Chief Financial Officer
03/03/2025
Buy
$30.93
25,000
$773K
25,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous